What this instrument does
The National Health (Listing of Pharmaceutical Benefits) Amendment (June Update) Instrument 2026 (reference F2026L00641) amends the National Health (Listing of Pharmaceutical Benefits) Instrument 2024 (PB 26 of 2024). That instrument is the legal rule that controls which medicines are listed on the Pharmaceutical Benefits Scheme (PBS) and what conditions apply to those listings. The amendment was made under the National Health Act 1953.
Key dates
- Commenced: 29 May 2026
- Applies until: 7 September 2026
What changed
The source document does not specify which particular medicines were added, removed, or changed in this June update. The full text of the instrument sets out exactly which medicines or conditions were affected from 29 May 2026.
Key actions
- Pharmacies and others who dispense PBS medicines are required to check the full text of F2026L00641 at https://www.legislation.gov.au/F2026L00641 to identify which medicines or conditions changed from 29 May 2026.
- Those who manage PBS billing or dispensing software are required to confirm their systems reflect any listing changes that took effect on 29 May 2026.
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.